DENTSPLY SIRONA Inc. (NASDAQ:XRAY) insider Mark Thierer purchased 77,000 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The stock was bought at an average cost of $66.04 per share, for a total transaction of $5,085,080.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

DENTSPLY SIRONA Inc. (XRAY) opened at $66.60 on Thursday. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21. DENTSPLY SIRONA Inc. has a 12 month low of $52.53 and a 12 month high of $67.95. The firm has a market cap of $15,113.13, a P/E ratio of 26.22, a price-to-earnings-growth ratio of 2.60 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same period last year, the company posted $0.66 EPS. The business’s revenue was up 5.8% on a year-over-year basis. sell-side analysts predict that DENTSPLY SIRONA Inc. will post 2.66 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Mark Thierer Buys 77,000 Shares of DENTSPLY SIRONA Inc. (XRAY) Stock” was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally copied and republished in violation of United States & international copyright laws. The correct version of this article can be read at https://www.dailypolitical.com/2017/11/16/mark-thierer-buys-77000-shares-of-dentsply-sirona-inc-xray-stock.html.

A number of research analysts recently weighed in on XRAY shares. UBS AG reaffirmed a “neutral” rating and issued a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. BidaskClub lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, October 30th. Jefferies Group LLC decreased their price target on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a research note on Wednesday, August 23rd. Finally, Cleveland Research lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Thursday, October 5th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $67.00.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Commonwealth Bank of Australia lifted its stake in DENTSPLY SIRONA by 19.0% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares in the last quarter. Acrospire Investment Management LLC purchased a new position in DENTSPLY SIRONA in the 2nd quarter worth approximately $113,000. Dupont Capital Management Corp purchased a new position in DENTSPLY SIRONA in the 2nd quarter worth approximately $116,000. Massey Quick Simon & CO. LLC purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $124,000. Finally, Korea Investment CORP raised its position in shares of DENTSPLY SIRONA by 139.9% during the 2nd quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after buying an additional 1,251 shares during the period. 94.65% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Insider Buying and Selling by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.